Clinical Trial Update: Efficacy and Safety of ADVATE Standard Prophylaxis to Hemophilia A [NA]

View source ↗

Summary

A clinical trial update evaluating the efficacy and safety of ADVATE Standard Prophylaxis in individuals with Hemophilia A, with status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• ADVATE (antihemophilic factor VIII)

Snippet

Sponsor: Nanjing Medical University | Conditions: Hemophilia A | NA | Status: UNKNOWN